Massachusetts Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $15.6M | Sell |
|
|||||
|
2017
Q2 | $13.6M | Sell |
|
|||||
|
2017
Q1 | $78.1M | Sell |
|
|||||
|
2016
Q4 | $79.7M | Sell |
|
|||||
|
2016
Q3 | $205M | Sell |
|
|||||
|
2016
Q2 | $245M | Buy |
|
|||||
|
2016
Q1 | $241M | Sell |
|
|||||
|
2015
Q4 | $405M | Buy |
|
|||||
|
2015
Q3 | $306M | Sell |
|
|||||
|
2015
Q2 | $388M | Sell |
|
|||||
|
2015
Q1 | $412M | Buy |
|
|||||
|
2014
Q4 | $424M | Buy |
|
|||||
|
2014
Q3 | $353M | Buy |
|
|||||
|
2014
Q2 | $330M | Buy |
|
|||||
|
2014
Q1 | $279M | Buy |
|
|||||
|
2013
Q4 | $237M | Buy |
|
|||||
|
2013
Q3 | $158M | Buy |
|
|||||
|
2013
Q2 | $106M | Buy |
|